{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:16:11Z","timestamp":1794586571463,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["No: 970204496"],"award-info":[{"award-number":["No: 970204496"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Substance-Related Disorders are among the most common social problems caused by using legal and illegal substances. Therefore, this study aimed at determining the quality of life (QoL) and its related factors among women with substance use disorders referring to substance abuse treatment centers in Hamadan, west of Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study was carried out on 120 Iranian female substance users recruited through the census sampling method in 2018. Data collection tools consisted of demographic characteristics and QoL assessment (SF-36). Data were analyzed using SPSS-16 via one-way analysis of variance (ANOVA) and chi-square tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of the participants was 33.2\u2009\u00b1\u200912.1\u00a0years and the mean score of their total QoL was 35.35\u2009\u00b1\u200913.5. The results of multiple linear regression analysis indicated that using methamphetamine (\u03b2\u2009=\u2009\u2009\u2212\u20096.62) was the predictor of QoL in women. Moreover, there was a significant association between QoL and age (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), educational level (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), and age at first use (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>According to the results, the participants\u2019 QoL was found to be at an unsatisfactory level. So, it is essential to implement educational help-seeking behavior for treatment and effectiveness educational, as well as holding mental health intervention, school-based substance abuse prevention, and harm reduction programs of substance use. This is especially important in adolescents, young, low-educated, early drug use, and methamphetamine user women, as it may increase the QoL<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-020-01155-7","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T16:03:31Z","timestamp":1609949011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Quality of life and its related factors in women with substance use disorders referring to substance abuse treatment centers"],"prefix":"10.1186","volume":"21","author":[{"given":"Majid","family":"Barati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Bandehelahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Nopasandasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-1473","authenticated-orcid":false,"given":"Hanieh","family":"Jormand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Keshavarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1155_CR1","unstructured":"Control UNOFD, Prevention C. World Drug Report: 2013: UN; 2013."},{"key":"1155_CR2","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2019: 35 million people worldwide suffer from drug use disorders while only 1 in 7 people receive treatment. 2019."},{"issue":"5","key":"1155_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/14659891.2016.1259363","volume":"22","author":"B Moeini","year":"2017","unstructured":"Moeini B, Barati M, Hazavehei SMM, Soltanian AR, Zareban I, Mousali AA. Applying theory of planned behavior to predict condom use intention among Iranian substance users covered by addiction treatment centers. J Subst Use. 2017;22(5):511\u20135.","journal-title":"J Subst Use"},{"issue":"4","key":"1155_CR4","first-page":"42","volume":"13","author":"B Moeini","year":"2015","unstructured":"Moeini B, Kafami V, Bashirian S, Barati M, Mousali AA. Factors predicting drug and psychoactive abuse among applicants for driving license in Hamadan using the theory of planned behavior in 2012. Pajouhan Sci J. 2015;13(4):42\u201350.","journal-title":"Pajouhan Sci J"},{"issue":"4","key":"1155_CR5","first-page":"125","volume":"1","author":"M Danesh","year":"2013","unstructured":"Danesh M, Maleki A. Grounded theory of the causes of addicted prisoners in central prison Esfahan. Socio-cult Dev Stud. 2013;1(4):125\u201345.","journal-title":"Socio-cult Dev Stud"},{"issue":"1","key":"1155_CR6","first-page":"1","volume":"15","author":"D Boostani","year":"2017","unstructured":"Boostani D, Karamizadeh E. Conditions and strategies of crystal (Methamphetamine) consumption among addicted women (Case study: Kerman City). Woman Dev Polit. 2017;15(1):1\u201320.","journal-title":"Woman Dev Polit"},{"key":"1155_CR7","first-page":"203","volume":"3","author":"MA Rahimi","year":"2004","unstructured":"Rahimi MA. A review on the prevalence and the patterns of drug abuse in women in Iran. Soc Welf. 2004;3:203\u201326.","journal-title":"Soc Welf"},{"issue":"10","key":"1155_CR8","first-page":"9","volume":"37","author":"V Farkhojasteh","year":"2015","unstructured":"Farkhojasteh V, Hossinian S. Relationship between high-risk and emotional behaviors and tendency to addiction in delinquent women. Intell Crim Res J. 2015;37(10):9\u201328.","journal-title":"Intell Crim Res J"},{"key":"1155_CR9","unstructured":"Ghader S, Nouri R, Karimi J, Morovat B. Etiology of women\u2019s addiction (a comparative study). 2017."},{"issue":"3","key":"1155_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF03403814","volume":"103","author":"S Jafari","year":"2012","unstructured":"Jafari S, Buxton JA, Afshar K, Copes R, Baharlou S. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health. 2012;103(3):207\u201312.","journal-title":"Can J Public Health"},{"issue":"4","key":"1155_CR11","first-page":"59","volume":"2","author":"T Khademian","year":"2008","unstructured":"Khademian T, Ghanaatian Z. Investigating the Social factors influencing addiction of women addicted to drugs in rehabilitation and harm reduction centers of Tehran women (Centers for rebirth, the House of the Sun). Soc Sci Bull. 2008;2(4):59\u201385.","journal-title":"Soc Sci Bull"},{"issue":"Spec Iss 3","key":"1155_CR12","first-page":"36","volume":"8","author":"F Ilika","year":"2015","unstructured":"Ilika F, Jamshidimanesh M, Hoseini M, Saffari M, Peyravi H. An evaluation of high-risk behaviors among female drug users based on Health Belief Model. J Med Life. 2015;8(Spec Iss 3):36.","journal-title":"J Med Life"},{"issue":"Suppl 1","key":"1155_CR13","first-page":"S131","volume":"3","author":"Z Nokhodian","year":"2012","unstructured":"Nokhodian Z, Meshkati M, Adibi P, Ataei B, Kassaian N, Yaran M, et al. Hepatitis C among intravenous drug users in Isfahan, Iran: a study of seroprevalence and risk factors. Int J Prev Med. 2012;3(Suppl 1):S131\u20138.","journal-title":"Int J Prev Med"},{"issue":"1","key":"1155_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1747-597X-10-5","volume":"10","author":"B Mej\u00eda","year":"2015","unstructured":"Mej\u00eda B, Zea P, Romero M, Sald\u00edvar G. Traumatic experiences and re-victimization of female inmates undergoing treatment for substance abuse. Subst Abuse Treat Prevent Policy. 2015;10(1):5.","journal-title":"Subst Abuse Treat Prevent Policy"},{"issue":"2","key":"1155_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/08897077.2018.1544184","volume":"40","author":"JD Cockroft","year":"2019","unstructured":"Cockroft JD, Adams SM, Bonnet K, Matlock D, McMillan J, Schlundt D. \u201cA scarlet letter\u201d: stigma and other factors affecting trust in the health care system for women seeking substance abuse treatment in a community setting. Subst Abus. 2019;40(2):170\u20137.","journal-title":"Subst Abus"},{"issue":"2","key":"1155_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5812\/ijhrba.10296","volume":"2","author":"M Khajedaluee","year":"2013","unstructured":"Khajedaluee M, Assadi R, Moghadam MD. Health-related quality of life of young addict women in Mashhad, IR Iran. Int J High Risk Behav Addict. 2013;2(2):87.","journal-title":"Int J High Risk Behav Addict"},{"issue":"3","key":"1155_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/ijnmr.IJNMR_199_18","volume":"25","author":"FS Seyed-Nematollah-Roshan","year":"2020","unstructured":"Seyed-Nematollah-Roshan FS, Alhani F, Zareiyan A, Kazemnejad A. Women\u2019s quality of life in Iran: a mixed method study. Iran J Nurs Midwifery Res. 2020;25(3):217.","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"4","key":"1155_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0306-4603(99)00040-4","volume":"25","author":"RS Falck","year":"2000","unstructured":"Falck RS, Wang J, Carlson RG, Siegal HA. Crack-cocaine use and health status as defined by the SF-36. Addict Behav. 2000;25(4):579\u201384.","journal-title":"Addict Behav"},{"issue":"3","key":"1155_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/0261018318795573","volume":"39","author":"S Flacks","year":"2019","unstructured":"Flacks S. Dangerous drugs, dangerous mothers: gender, responsibility and the problematisation of parental substance use. Crit Soc Policy. 2019;39(3):477\u201397.","journal-title":"Crit Soc Policy"},{"issue":"3","key":"1155_CR20","first-page":"221","volume":"14","author":"M Barati","year":"2014","unstructured":"Barati M, Ahmadpanah M, Soltanian AR. Prevalence and factors associated with methamphetamine use among adult substance abusers. J Res Health Sci. 2014;14(3):221\u20136.","journal-title":"J Res Health Sci"},{"key":"1155_CR21","unstructured":"Montazeri A, Goshtasebi A, Vahdaninia M.S. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Health Monit J Iran Inst Health Sci Res. 2006;5(1). http:\/\/payeshjournal.ir\/article-1-756-fa.html. Accessed 2018."},{"key":"1155_CR22","unstructured":"Australian Goverment DoH. National Drug Strategy 2017\u20132026, A ten-year framework that aims to reduce and prevent the harmful effects of alcohol, tobacco and other drugs. 2017. Retrieved from: https:\/\/www.health.gov.au\/resources\/publications\/national-drug-strategy-2017-2026."},{"issue":"1","key":"1155_CR23","first-page":"337","volume":"13","author":"A Farhoudian","year":"2014","unstructured":"Farhoudian A, Sadeghi M, Khoddami Vishteh HR, Moazen B, Fekri M, Rahimi MA. Component analysis of Iranian crack; a newly abused narcotic substance in Iran. Iran J Pharm Res. 2014;13(1):337\u201344.","journal-title":"Iran J Pharm Res"},{"issue":"23","key":"1155_CR24","first-page":"65","volume":"6","author":"H Mardani","year":"2012","unstructured":"Mardani H, Sheikhi Fini A, Kavousian J. Prevalence of drug use among students of Islamic Azad University of Bandar Abbas. Res Addict. 2012;6(23):65\u201382.","journal-title":"Res Addict"},{"issue":"1","key":"1155_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12955-016-0439-1","volume":"14","author":"AE Muller","year":"2016","unstructured":"Muller AE, Skurtveit S, Clausen T. Many correlates of poor quality of life among substance users entering treatment are not addiction-specific. Health Qual Life Outcomes. 2016;14(1):39.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1155_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2012.01.010","volume":"124","author":"EM Tracy","year":"2012","unstructured":"Tracy EM, Laudet AB, Min MO, Kim H, Brown S, Jun MK, et al. Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug Alcohol Depend. 2012;124(3):242\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1155_CR27","doi-asserted-by":"publisher","first-page":"152193","DOI":"10.1016\/j.comppsych.2020.152193","volume":"102","author":"BE Kavanagh","year":"2020","unstructured":"Kavanagh BE, Stuart AL, Berk M, Turner A, Dean OM, Pasco JA, et al. Personality disorder increases risk of low quality of life among women with mental state disorders. Compr Psychiatry. 2020;102:152193.","journal-title":"Compr Psychiatry"},{"issue":"11","key":"1155_CR28","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4088\/JCP.14m09271","volume":"76","author":"K Penner-Goeke","year":"2015","unstructured":"Penner-Goeke K, Henriksen CA, Chateau D, Latimer E, Sareen J, Katz LY. Reductions in quality of life associated with common mental disorders: results from a nationally representative sample. J Clin Psychiatry. 2015;76(11):1506\u201312.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"1155_CR29","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.3390\/ijerph17103680","volume":"17","author":"J Gim\u00e9nez-Meseguer","year":"2020","unstructured":"Gim\u00e9nez-Meseguer J, Tortosa-Mart\u00ednez J, Cortell-Tormo JM. The benefits of physical exercise on mental disorders and quality of life in substance use disorders patients: systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17(10):3680.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"1155_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3109\/01612840.2013.780118","volume":"34","author":"M Marini","year":"2013","unstructured":"Marini M, Schnornberger TM, Brandalise GB, Bergozza M, Heldt E. Quality of life determinants in patients of a psychosocial care center for alcohol and other drug users. Issues Ment Health Nurs. 2013;34(7):524\u201330.","journal-title":"Issues Ment Health Nurs"},{"key":"1155_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/jehp.jehp_297_13","volume":"6","author":"N Sadeghi","year":"2017","unstructured":"Sadeghi N, Davaridolatabadi E, Rahmani A, Ghodousi A, Ziaeirad M. Quality of life of adolescents and young people arrive at an addiction treatment centers upon their admission, and 1, 4 and 8 months after methadone maintenance therapy. J Educ Health Promot. 2017;6:95.","journal-title":"J Educ Health Promot"},{"issue":"2","key":"1155_CR32","first-page":"111","volume":"13","author":"R Mihan","year":"2018","unstructured":"Mihan R, Shahrivar Z, Mahmoudi-Gharaei J, Shakiba A, Hosseini M. Attention-deficit hyperactivity disorder in adults using methamphetamine: does it affect comorbidity, quality of life, and global functioning? Iran J Psychiatry. 2018;13(2):111\u20138.","journal-title":"Iran J Psychiatry"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-01155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-020-01155-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-01155-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T18:05:56Z","timestamp":1610215556000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-01155-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-01155-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18977\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18977\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18977\/v3","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the women were informed about the quality of the project\u2019s implementation, confidentiality of the information, and the project\u2019s purpose. They were not enrolled in the study unless they would like. Participants indicated their informed consent by clicking the \u201cI Agree\u201d button before completing the questionnaire. Also, the number of participants under 16\u00a0years without any parents was low (n\u2009=\u20093). According to the guidelines of the Iranian ethics committee, the participants were considered emancipated minors. Thus, written informed consent was received from them and the care centers\u2019 manager. The Ethics Committee approved this study with all consent process at Hamadan University of Medical Sciences (No: IR.UMSHA.REC.1397.3).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"16"}}